Post-Operative Use of FS2 to Mitigate Scarring in Burn Patients
Status:
NOT_YET_RECRUITING
Trial end date:
2026-11-06
Target enrollment:
Participant gender:
Summary
The goal of this study is to see how an ingredient called kynurenic acid (which we named "FS2") affects scar formation in people with burn injuries that need skin graft surgery. A cream with FS2 will be used on both the area where the skin graft was placed and the area where the skin was taken (donor site). The cream will be applied after the skin has healed. This study will help us understand if FS2 is safe and effective for mitigating skin scar formation in burn patients.
Phase:
PHASE2
Details
Lead Sponsor:
Birch BioMed Inc
Collaborator:
Nutrasource Pharmaceutical and Nutraceutical Services, Inc.